MeMed
PrivateLast Round
VC Round
Jan 10, 2022
Total Funding Raised
$98.03M
Momentum Score
25 /100
Company Overview
MeMed is a healthcare technology company that develops immuno-personalized diagnostic devices to rapidly identify bacterial and viral infections by analyzing patients' immune responses, thereby assisting physicians in making informed antibiotic treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MeMed Comps
Public and private peers based on sector, stage, and business model.
MeMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 10, 2022 | ||||
| Grant | Nov 13, 2019 | ||||
| Series C | Sep 20, 2018 | ||||
| Grant | Feb 6, 2018 | ||||
| Grant | Apr 19, 2017 | ||||
Grant | Sep 18, 2015 |
Key People
Founding team and executive leadership
MeMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series B, Series C, VC Round |
| European Innovation Council | Grant |
| Union Tech Ventures | VC Round |
| European Commission (Horizon Europe) | Grant |
| Clal Insurance | Series C |
| S28 Capital | Series C |
| Touchwood Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Developing a next-generation AIVD product.
- Mar 1, 2026
Diagnostic technology receives FDA clearance and is in use.
MeMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MeMed's valuation, stock price, and market status.